New clinical trials in Georgia: 148 since Nov 2024

Name: New clinical trials in Georgia
Creator: SpecStream
License: https://creativecommons.org/licenses/by/4.0/

The full list. New clinical trials with a site in Georgia: 148 rows for $7.40, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. The list gains about 4 rows a month. The new rows come each week by email, $19 a month.

Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (central contact, contact phone, contact email, sponsor class, condition groups (MeSH), interventions and 5 more), which open on your screen as soon as the payment clears and come by email. The weekly rows run until you cancel, from the link in each delivery. The rows on this page are a sample.

For agents and scripts: this list is ordered at https://specstream.ai/data/clinical-trials/country/georgia, and every list with its row count and price is at https://specstream.ai/data/lists.json.

Updated November 4, 2026. Source: ClinicalTrials.gov API v2 (U.S. National Library of Medicine).

148 clinical studies with a site in Georgia were first posted on ClinicalTrials.gov from November 12, 2024 to November 4, 2026; 136 have an industry sponsor and 105 are recruiting or about to. The newest, NCT07916103, was posted on November 4, 2026: HA-Coated and Non-HA Threads for Midface Lifting and Nasolabial Fold Correction (Aptos, LLC.).

The request: Every new clinical trial with a site in Georgia, with the sponsor, phase, conditions and the listed contact. $10 of credit on sign-up, no card.

Get new trials like these Watch a sponsor

SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.

148New trials
136Industry sponsored
105Recruiting or not yet
November 4, 2026Latest posted

Newest trials

The newest 100 of 148, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.

First posted	NCT ID	Title	Sponsor	Phase	Status	Conditions	Enrollment	Countries	Source
November 4, 2026	NCT07916103	HA-Coated and Non-HA Threads for Midface Lifting and Nasolabial Fold Correction	Aptos, LLC.	Not applicable	Completed	Nasolabial Fold Correction, Midface	144	Georgia	clinicaltrials.gov
November 3, 2026	NCT07911800	rhTPO for Thrombocytopenia in Chronic Liver Disease Patients Undergoing Elective Invasive Procedures.	MIBIO PTE. LTD.	Phase 3	Recruiting	Thrombocytopenia Associated With Chronic Liver Disease	150	Georgia	clinicaltrials.gov
October 21, 2026	NCT07885891	Cefepime-Zidebactam Versus Ceftazidime-Avibactam With or Without Colistin for Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia	Wockhardt	Phase 3	Not yet recruiting	Hospital Acquired Bacterial Pneumonia (HABP), Ventilator Associated Bacterial Pneumonia (VABP)	324	Bosnia and Herzegovina, Bulgaria, Croatia, France, Georgia, Greece, India...	clinicaltrials.gov
October 16, 2026	NCT07877051	A Clinical Study of the Aqua Therapeutics Thermal Therapy Vapor Ablation System in Premenopausal Women With Abnormal Uterine Bleeding	Aqua Therapeutics, Inc.	Not applicable	Recruiting	Menorrhagia	43	Georgia	clinicaltrials.gov
October 5, 2026	NCT07858643	A Study of LDGraft In Single Level Lumbar Interbody Fusion	Locate Bio Ltd	Phase 1/2	Recruiting	Degenerative Disc Disease Lumbar	25	Georgia	clinicaltrials.gov
October 1, 2026	NCT07851025	Torvutatug Samrotecan Plus Bevacizumab as First-line Maintenance in Non-Homologous Recombination Deficiency (Non-HRD) Positive Advanced...	AstraZeneca	Phase 3	Recruiting	Epithelial Ovarian Cancer	950	Argentina, Australia, Brazil, Bulgaria, Canada, Chile, China, Colombia...	clinicaltrials.gov
September 29, 2026	NCT07845487	A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis	Palisade Bio	Phase 2	Recruiting	Ulcerative Colitis (UC), Severe Ulcerative Colitis, Moderate Ulcerative Colitis	204	Canada, Czechia, France, Georgia, Hungary, Italy, Latvia, Poland, Romania...	clinicaltrials.gov
September 22, 2026	NCT07832409	Cranberry Proanthocyanidins and Lactobacilli for Recurrent UTI Prevention in Type 2 Diabetes	National Institute of Endocrinology, Georgia	Not applicable	Completed	Type 2 Diabetes Mellitus (T2DM), Recurrent Urinary Tract Infections	100	Georgia	clinicaltrials.gov
September 9, 2026	NCT07810335	Evaluation of FlowMod System While Intermittently Partially Occluding Vena Cava Blood Flow in Subjects With ADHF	FlowMod, Inc.	Not applicable	Not yet recruiting	Acute Decompensated Heart Failure (ADHF)	30	Georgia, Uzbekistan	clinicaltrials.gov
September 1, 2026	NCT07796659	EXPLORE MRace (GE): Early Feasibility Experience of Posterior Leaflet Restoration to Reduce Mitral Regurgitation Using the MRace Implant	Polares Medical SA	Not applicable	Recruiting	Mitral Valve Disease	100	Georgia	clinicaltrials.gov
August 21, 2026	NCT07779616	Study of PTC844 in Participants With Active Rheumatoid Arthritis	PTC Therapeutics	Phase 2	Recruiting	Rheumatoid Arthritis	75	Georgia, Mauritius, South Africa, United States	clinicaltrials.gov
August 13, 2026	NCT07762027	A Study to Assess the Safety, Pharmacokinetics, and Efficacy of ABI-6250 in Participants With Chronic Hepatitis D Virus Infection	Assembly Biosciences	Phase 2	Not yet recruiting	Chronic Hepatitis D Infection	80	France, Georgia, Germany, Italy, Moldova, New Zealand, Pakistan, Romania...	clinicaltrials.gov
August 4, 2026	NCT07745387	Effect of a Topical Cetylated Fatty Acid Cream on Pain Relief in Patients With Knee Osteoarthritis	Pharmanutra S.p.a.	Not applicable	Completed	Knee Osteoarthristis	156	Georgia	clinicaltrials.gov
July 15, 2026	NCT07704099	Safety and Efficacy of KER-065 in Participants With Duchenne Muscular Dystrophy	Keros Therapeutics, Inc.	Phase 2	Recruiting	Duchenne Muscular Dystrophy	36	Georgia, New Zealand	clinicaltrials.gov
July 13, 2026	NCT07697599	Venous Thromboembolism (VTE) Prophylaxis With REGN7508 and REGN9933 in Adult and Adolescent Participants With a Peripherally Inserted...	Regeneron Pharmaceuticals	Phase 3	Recruiting	Venous Thromboembolism (VTE)	1,908	Georgia	clinicaltrials.gov
July 6, 2026	NCT07684820	To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment	Expedition Therapeutics, Inc	Phase 2	Recruiting	Chronic Obstructive Pulmonary Disease (COPD)	600	Canada, Georgia, Moldova, United States	clinicaltrials.gov
June 17, 2026	NCT07652294	Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD	Spyre Therapeutics, Inc.	Phase 2	Enrolling by invitation	Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis, Colitis, Ulcerative	645	Argentina, Australia, Austria, Belgium, Brazil, Chile, Czechia, Georgia...	clinicaltrials.gov
June 15, 2026	NCT07647510	A Phase 3 Study to Evaluate Claseprubart in Adults With Generalized Myasthenia Gravis (EMERGE)	Dianthus Therapeutics	Phase 3	Recruiting	Myasthenia Gravis, Generalized	195	Georgia, Ukraine, United States	clinicaltrials.gov
June 4, 2026	NCT07627022	Impact of a Reminder App on Physical Activity During Radiation Therapy for Lung Cancer	University Hospital Schleswig-Holstein	Not applicable	Not yet recruiting	Lung Cancer	32	Denmark, Georgia, Germany, Slovenia	clinicaltrials.gov
June 4, 2026	NCT07625644	BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)	SystImmune Inc.	Phase 3	Recruiting	Small Cell Lung Cancer Extensive Stage, Small-cell Lung Cancer, Small Cell Carcinoma, Sclc, SCLC,Extensive Stage, Lung...	550	Australia, Bulgaria, Canada, Czechia, France, Georgia, Germany, Greece...	clinicaltrials.gov
June 3, 2026	NCT07623200	A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia	Incyte Corporation	Phase 3	Recruiting	Essential Thrombocythemia	426	Australia, Austria, Belgium, Canada, Czechia, France, Georgia, Germany...	clinicaltrials.gov
May 28, 2026	NCT07610564	A Study to Assess the Effect of Empasiprubart on Nerve Morphology by Ultrasound in Adults With Multifocal Motor Neuropathy	argenx	Phase 1	Recruiting	Multifocal Motor Neuropathy (MMN)	60	Georgia	clinicaltrials.gov
May 20, 2026	NCT07598760	Clinical Feasibility of Cardiac Neuromodulation Therapy for Heart Failure With Preserved Ejection Fraction	BackBeat Medical Inc	Not applicable	Not yet recruiting	Hypertension (HTN), Heart Failure With Preserved Ejection Fraction (HFpEF, Hypertension, Systolic	20	Georgia	clinicaltrials.gov
May 19, 2026	NCT07596849	A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease.	argenx	Phase 3	Recruiting	Graves Disease	230	Belgium, Bulgaria, Canada, Denmark, Georgia, Germany, Greece, Italy, Japan...	clinicaltrials.gov
May 6, 2026	NCT07570316	A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease	argenx	Phase 3	Recruiting	Graves' Disease, Graves Disease	230	Georgia, United Kingdom, United States	clinicaltrials.gov
May 1, 2026	NCT07562152	Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma	Immuneering Corporation	Phase 3	Recruiting	Pancreatic Cancer, Pancreatic Cancer Metastatic, PDAC, PDAC - Pancreatic Ductal Adenocarcinoma, Pancreatic Ductal...	570	Australia, Georgia, Germany, Hungary, Poland, Romania, Spain, United Kingdom...	clinicaltrials.gov
April 20, 2026	NCT07540572	A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid...	IDEAYA Biosciences	Phase 1	Recruiting	Cancer	155	Georgia, United States	clinicaltrials.gov
April 16, 2026	NCT07533955	A Phase 1 Study of JADE201 in Participants With Rheumatoid Arthritis	Jade Biosciences, Inc.	Phase 1	Recruiting	Rhematoid Arthritis	36	Bulgaria, Georgia, Germany, Moldova, Romania, Ukraine	clinicaltrials.gov
April 13, 2026	NCT07522073	A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal...	Incyte Corporation	Phase 3	Recruiting	Solid Tumors	588	Australia, Austria, Belgium, Canada, Denmark, Finland, France, Georgia...	clinicaltrials.gov
March 31, 2026	NCT07503873	A Study to Evaluate Pharmacokinetics (PK) and Safety of Subcutaneous (SC) Ublituximab Administered at Various Injection Sites and Relative...	TG Therapeutics, Inc.	Phase 2	Recruiting	Multiple Sclerosis	350	Bosnia and Herzegovina, Georgia, North Macedonia, Poland, Serbia, Ukraine	clinicaltrials.gov
March 31, 2026	NCT07503444	A Phase 3 Study of Fenfluramine Hydrochloride in Rett Syndrome	UCB BIOSCIENCES, Inc.	Phase 3	Recruiting	Rett Syndrome	200	Belgium, France, Georgia, Germany, Hungary, Israel, Italy, Japan, Poland...	clinicaltrials.gov
March 27, 2026	NCT07497087	A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis	Boehringer Ingelheim	Phase 3	Recruiting	Systemic Sclerosis	448	Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, China...	clinicaltrials.gov
March 17, 2026	NCT07477587	A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With...	Shanghai Henlius Biotech	Phase 1	Recruiting	Multiple Myeloma (MM)	258	Australia, China, Georgia, Serbia, United States	clinicaltrials.gov
March 17, 2026	NCT07476326	Pharmacokinetics, Safety, and Immunogenicity Comparison of Bmab1700 and Opdivo® as Adjuvant Monotherapy in Participants With Melanoma	Biocon Biologics UK PLC	Phase 1	Recruiting	Melanoma	120	Brazil, Chile, Georgia, Moldova, Romania, Serbia, South Africa, Spain, Turkey...	clinicaltrials.gov
March 16, 2026	NCT07472517	DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and...	Boehringer Ingelheim	Phase 3	Recruiting	Small Cell Lung Cancer (SCLC), Extensive-stage Small Cell Lung Cancer (ES-SCLC)	670	Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, China...	clinicaltrials.gov
March 16, 2026	NCT07472491	A Phase 2/3 Study on the Efficacy and Safety of Mangaciclanol for Contrast-Enhanced MRI of CNS or Body in Adult Patients	GE Healthcare	Phase 2/3	Recruiting	Known or Highly Suspected Central Nervous System (CNS) Lesion, Known or Highly Suspected Body (Excluding CNS) Lesion	640	Georgia, Moldova, South Korea, United States	clinicaltrials.gov
March 11, 2026	NCT07465289	A Study to Evaluate The Long-Term Safety And Efficacy of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis	UCB Biopharma SRL	Phase 3	Recruiting	Ocular Myasthenia Gravis	100	China, France, Georgia, Japan, Poland, Spain, United States	clinicaltrials.gov
March 11, 2026	NCT07463521	A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis	UCB Biopharma SRL	Phase 3	Recruiting	Ocular Myasthenia Gravis	120	Canada, China, France, Georgia, Germany, Japan, Poland, Spain, United States	clinicaltrials.gov
March 5, 2026	NCT07450911	The REValve Clinical Trial an Evaluation Of the ReValve Palmetto Valve for the Replacement of the Native Mitral VaLVE	ReValve Solutions Inc.	Phase 1	Recruiting	Mitral Regurgitation	20	Georgia	clinicaltrials.gov
February 27, 2026	NCT07438496	A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus	Janssen Research & Development, LLC	Phase 3	Recruiting	Lupus Erythematosus, Systemic	600	Argentina, Australia, Brazil, Bulgaria, China, Czechia, Denmark, Finland...	clinicaltrials.gov
February 25, 2026	NCT07433335	A Study to Assess the Safety and Tolerability of SR-878 in Patients With Rheumatoid Arthritis	SciRhom GmbH	Phase 1	Recruiting	Rheumatoid Arthritis	27	Georgia, Moldova, Romania	clinicaltrials.gov
February 24, 2026	NCT07431112	A Study of AIR-001 in Adults With Alpha-1 Antitrypsin Deficiency (AATD)	AIRNA Corporation	Phase 1	Recruiting	Alpha 1 Antitrypsin Deficiency	54	Australia, Georgia, Germany, Netherlands, New Zealand, Portugal, Spain, Sweden...	clinicaltrials.gov
February 13, 2026	NCT07410117	REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis	Regeneron Pharmaceuticals	Phase 3	Recruiting	Cancer-Associated Thrombosis (CAT)	1,120	Georgia, Japan, United States	clinicaltrials.gov
February 12, 2026	NCT07407816	Feasibility Study of the Supira System in Patients Undergoing HRPCI With Support Beyond the PCI Procedure	Supira Medical	Not applicable	Recruiting	Heart Disease, Coronary Arterial Disease (CAD), Heart Failure	45	Georgia	clinicaltrials.gov
February 12, 2026	NCT07404865	Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease	Vor Biopharma	Phase 3	Recruiting	Primary Sjogren's Disease	250	Georgia, United States	clinicaltrials.gov
February 11, 2026	NCT07403058	Endovascular Ablation of the Right Greater Splanchnic Nerve in Subjects With Reduced Ejection Fraction	Axon Therapies, Inc.	Not applicable	Recruiting	Heart Failure With Reduced Ejection Fraction (HFrEF)	50	Czechia, Georgia, Poland, Spain, United Kingdom	clinicaltrials.gov
February 11, 2026	NCT07402915	Drug-drug Interaction Study With AZD5335 and Itraconazole in Participants With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer	AstraZeneca	Phase 1	Recruiting	Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal	32	Georgia, Ireland, Portugal, Spain	clinicaltrials.gov
February 6, 2026	NCT07391670	A Phase I Dose Escalation and Dose Expansion Study to Investigate the Pharmacokinetics and Safety of Subcutaneous Durvalumab	AstraZeneca	Phase 1	Recruiting	Solid Tumours	40	Australia, Georgia, Poland, South Korea, Taiwan	clinicaltrials.gov
February 3, 2026	NCT07384975	A Study to Assess NAV-240 in Adult Participants With Hidradenitis Suppurativa	Navigator Medicines, Inc.	Phase 2	Recruiting	Hidradenitis Suppurativa (HS)	150	Bulgaria, Canada, Georgia, Germany, Hungary, Poland, Romania, United States	clinicaltrials.gov
February 2, 2026	NCT07380815	Physical Activity During Radiation Therapy for Lung Cancer	University Hospital Schleswig-Holstein	Observational	Completed	Prospective Study	20	Denmark, Georgia, Germany, Slovenia	clinicaltrials.gov
January 30, 2026	NCT07378644	Study to Evaluate the Pharmacodynamics, Safety and Efficacy of SKY-0515 in Participants With Huntington's Disease	Skyhawk Therapeutics, Inc.	Phase 2/3	Recruiting	Huntington Disease	400	Argentina, Brazil, Canada, Chile, Colombia, Georgia, Germany, Spain, United...	clinicaltrials.gov
January 29, 2026	NCT07376070	The Role of Inflammatory Biomarkers in Preventing Deep Sternal Wound Infections After Sternotomy	Levan Nebieridze	Observational	Active not recruiting	Deep Sternal Infection, Diabete Mellitus, Mediastinitis	30	Georgia	clinicaltrials.gov
January 28, 2026	NCT07374471	A Study of MB-001 in Moderately to Severely Active Ulcerative Colitis	Mage Biologics	Phase 1/2	Recruiting	Ulcerative Colitis (UC)	100	Georgia, Moldova, Poland, Ukraine	clinicaltrials.gov
January 23, 2026	NCT07363590	A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004)	Merck Sharp & Dohme LLC	Phase 1	Recruiting	Systemic Lupus Erythematosus, Rheumatoid Arthritis	21	Australia, Belgium, China, Colombia, Georgia, Italy, Japan, Moldova, Peru...	clinicaltrials.gov
January 22, 2026	NCT07359846	A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)	Generate Biomedicines	Phase 3	Recruiting	Severe Asthma	786	Argentina, Australia, Belgium, Estonia, France, Georgia, India, Ireland, Italy...	clinicaltrials.gov
January 8, 2026	NCT07326540	Efficacy and Safety of BV100 Plus Low Dose Polymyxin B Versus Colistin Plus High-dose Ampicillin/Sulbactam in Patients With...	BioVersys SAS	Phase 3	Recruiting	Hospital Acquired Bacterial Pneumonia (HABP), Ventilator Associated Bacterial Pneumonia (VABP), Colistin Resistanrt...	248	Georgia	clinicaltrials.gov
December 23, 2025	NCT07299019	A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis	Zenas BioPharma (USA), LLC	Phase 3	Recruiting	Secondary Progressive Multiple Sclerosis	990	Australia, Belgium, Bulgaria, Croatia, Czechia, Estonia, France, Georgia...	clinicaltrials.gov
December 23, 2025	NCT07298330	A Trial Evaluating Brelovitug vs Delayed Treatment for the Treatment of Chronic Hepatitis Delta Infection (AZURE-4)	Mirum Pharmaceuticals, Inc.	Phase 3	Active not recruiting	Chronic Hepatitis D Infection	80	Belgium, Bulgaria, Georgia, Hungary, Israel, Pakistan, Taiwan, Ukraine, United...	clinicaltrials.gov
December 22, 2025	NCT07296315	Confirmatory Clinical Study in Active Ulcerative Colitis	MRM Health NV	Phase 2	Recruiting	Colitis, Ulcerative	204	Czechia, Georgia, Moldova, Poland, Serbia, Ukraine, United States	clinicaltrials.gov
December 19, 2025	NCT07293923	Magenta Elevate™ Clinical Feasibility Study in Cardiogenic Shock	Magenta Medical Ltd.	Not applicable	Recruiting	Cardiogenic Shock, Heart Failure, Acute Myocardial Infarction (AMI)	10	Georgia, Israel	clinicaltrials.gov
December 16, 2025	NCT07286006	A Long-Term Extension Study of IMVT-1402 in Adult Participants With Graves' Disease (GD)	Immunovant Sciences GmbH	Phase 2	Enrolling by invitation	Graves' Disease	372	Australia, Bulgaria, Czechia, Georgia, Hungary, Israel, Latvia, Poland, South...	clinicaltrials.gov
December 16, 2025	NCT07284849	A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line...	Incyte Corporation	Phase 3	Recruiting	CRC (Colorectal Cancer)	700	Argentina, Australia, Austria, Belgium, Brazil, Canada, China, Denmark, France...	clinicaltrials.gov
December 12, 2025	NCT07280156	A Study to Investigate the Clinical Effect and the Safety of PRX-115 Infused Intravenously at Different Dosing Regimens, With and Without...	Protalix	Phase 2	Recruiting	Gout	150	Georgia, Israel, United States	clinicaltrials.gov
December 3, 2025	NCT07260877	A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety...	Ventus Therapeutics U.S., Inc.	Phase 2	Active not recruiting	Cutaneous Lupus Erythematosus (CLE), Systemic Lupus Erythematosus, SLE, SLE (Systemic Lupus), CLE	24	Bulgaria, France, Georgia, Hungary, Poland, South Africa, Spain, United States	clinicaltrials.gov
December 1, 2025	NCT07256392	Long-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria	Celldex Therapeutics	Phase 3	Enrolling by invitation	Chronic Spontaneous Urticaria	1,370	Argentina, Australia, Belgium, Bulgaria, Canada, Chile, Colombia, Czechia...	clinicaltrials.gov
November 18, 2025	NCT07234032	An Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With...	Insmed Incorporated	Phase 3	Recruiting	Pulmonary Hypertension, Interstitial Lung Disease	344	Czechia, France, Georgia, Germany, Japan, South Korea, Spain, United States	clinicaltrials.gov
November 17, 2025	NCT07230834	Intravitreal (IVT) Pozelimab for Geographic Atrophy (GA) in Adult Participants	Regeneron Pharmaceuticals	Phase 1	Recruiting	Geographic Atrophy (GA)	54	Georgia, Puerto Rico, Romania, United States	clinicaltrials.gov
November 17, 2025	NCT07230353	A Phase 1b Open-label Study to Evaluate Safety of Plamotamab in Participants With Rheumatoid Arthritis	Xencor, Inc.	Phase 1	Recruiting	Rheumatoid Arthritis	68	Georgia, Moldova, New Zealand	clinicaltrials.gov
November 3, 2025	NCT07223658	Study of ARO-DIMERPA in Adult Participants With Mixed Hyperlipidemia	Arrowhead Pharmaceuticals	Phase 1/2	Recruiting	Hyperlipidemia; Mixed	78	Australia, Canada, Georgia, Moldova, New Zealand	clinicaltrials.gov
October 28, 2025	NCT07221734	Study to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB11 Versus EU-/US-Opdivo® in Subjects With Previously Untreated...	mAbxience Research S.L.	Phase 3	Recruiting	Advanced (Unresectable or Metastatic) Melanoma	632	Bosnia and Herzegovina, Brazil, Chile, Georgia, Greece, Italy, Peru, Portugal...	clinicaltrials.gov
October 23, 2025	NCT07220083	A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)	Boehringer Ingelheim	Phase 3	Recruiting	Focal Segmental Glomerulosclerosis	286	Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, China, Croatia...	clinicaltrials.gov
October 8, 2025	NCT07211958	Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation	Syndax Pharmaceuticals	Phase 3	Recruiting	Acute Myeloid Leukemias	468	Argentina, Australia, Austria, Belgium, Brazil, Canada, France, Georgia...	clinicaltrials.gov
October 8, 2025	NCT07211633	A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, Radiological and Clinical Effects of Subcutaneous Ublituximab in...	TG Therapeutics, Inc.	Phase 3	Active not recruiting	Relapsing Multiple Sclerosis	360	Bosnia and Herzegovina, Bulgaria, Croatia, Czechia, Georgia, Hungary, North...	clinicaltrials.gov
October 7, 2025	NCT07209761	A Study of Quabodepistat-containing Regimens for the Treatment of Drug-resistant Pulmonary Tuberculosis	Otsuka Pharmaceutical Development & Commercialization, Inc.	Phase 3	Recruiting	Rifampicin-Resistant Pulmonary Tuberculosis, Multidrug-Resistant Pulmonary Tuberculosis	532	China, Georgia, India, Indonesia, Japan, Moldova, Peru, Philippines, South...	clinicaltrials.gov
October 6, 2025	NCT07207954	Study of LFD-200 in Healthy Adults and Adults With Moderate to Severe Rheumatoid Arthritis	Lifordi Immunotherapeutics, Inc.	Phase 1	Recruiting	Rheumatoid Arthritis	176	Australia, Georgia, Moldova, Poland, Ukraine	clinicaltrials.gov
September 24, 2025	NCT07190209	Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic...	Sanofi	Phase 3	Recruiting	Chronic Obstructive Pulmonary Disease	942	Argentina, Belgium, Brazil, Canada, Chile, China, Denmark, Estonia, Finland...	clinicaltrials.gov
September 23, 2025	NCT07188233	Mitral Annular Repair With the CathHELIX™ Transcatheter System in Subjects With FMR	HVR Cardio Oy	Not applicable	Recruiting	Mitral Valve Regurgitation (Degenerative or Functional)	5	Georgia, Lithuania	clinicaltrials.gov
September 22, 2025	NCT07185009	A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative...	Sanofi	Phase 3	Recruiting	Ulcerative Colitis	751	Argentina, Australia, Austria, Belgium, Bulgaria, Canada, Chile, China...	clinicaltrials.gov
September 22, 2025	NCT07184996	An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis	Sanofi	Phase 3	Recruiting	Ulcerative Colitis	980	Argentina, Australia, Austria, Bulgaria, Canada, China, Czechia, France...	clinicaltrials.gov
September 22, 2025	NCT07184944	A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease	Sanofi	Phase 3	Recruiting	Crohn's Disease	751	Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, China, Czechia...	clinicaltrials.gov
September 22, 2025	NCT07184931	An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease	Sanofi	Phase 3	Recruiting	Crohn's Disease	980	Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, China...	clinicaltrials.gov
September 17, 2025	NCT07179380	Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With...	Insmed Incorporated	Phase 3	Recruiting	Pulmonary Hypertension, Interstitial Lung Disease	344	Argentina, Australia, Austria, Belgium, Brazil, Colombia, Czechia, Denmark...	clinicaltrials.gov
September 15, 2025	NCT07173751	ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer	BioNTech SE	Phase 3	Recruiting	Breast Neoplasms	558	Argentina, Australia, Belgium, Brazil, Canada, China, Czechia, Georgia...	clinicaltrials.gov
September 9, 2025	NCT07162883	Pharmacokinetic Study of QL2107 Versus Keytruda® for Adjuvant Therapy of Non-Small Cell Lung Cancer (NSCLC)	Qilu Pharmaceutical Co., Ltd.	Phase 3	Active not recruiting	Carcinoma, Non-Small-Cell Lung	146	Bosnia and Herzegovina, China, Georgia, Greece, Hungary, India, Poland...	clinicaltrials.gov
September 8, 2025	NCT07160335	A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multiple Resected Solid...	Shanghai Henlius Biotech	Phase 1	Active not recruiting	Non-small Cell Lung Cancer, Melanoma, Renal Cell Carcinoma	174	China, Georgia, Turkey (Türkiye), United States	clinicaltrials.gov
August 29, 2025	NCT07148414	A Study of SPY072 in Rheumatic Disease	Spyre Therapeutics, Inc.	Phase 2	Active not recruiting	Rheumatoid Arthritis, Psoriatic Arthritis, Axial Spondyloarthritis, Rheumatic Diseases, Rheumatic Joint Disease, PsA...	285	Bulgaria, Czechia, Georgia, Moldova, Poland, Spain, Ukraine, United States	clinicaltrials.gov
August 22, 2025	NCT07135622	Xpert MTB/RIF Ultra Trial	Nestani Tukvadze	Not applicable	Completed	Tuberculosis (TB), Pulmonary TB	778	Georgia	clinicaltrials.gov
August 11, 2025	NCT07115004	Study to Evaluate Subcutaneous (SC) VGA039 in Patients With Von Willebrand Disease (VWD)	Vega Therapeutics, Inc	Phase 3	Recruiting	Von Willebrand Disease (VWD)	60	Australia, Austria, Brazil, Georgia, Germany, Ireland, Italy, South Africa...	clinicaltrials.gov
August 8, 2025	NCT07113522	A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease	Mirador Therapeutics, Inc.	Phase 2	Recruiting	Inflammatory Bowel Disease (IBD), Ulcerative Colitis (UC), Crohn's Disease	140	Canada, Georgia, Moldova, Ukraine, United States	clinicaltrials.gov
July 31, 2025	NCT07096843	A Phase 2 Study of Budoprutug in Subjects With Primary Membranous Nephropathy	Climb Bio, Inc.	Phase 2	Recruiting	Primary Membranous Nephropathy	45	Argentina, Brazil, China, Georgia, Taiwan, Ukraine, United States	clinicaltrials.gov
July 29, 2025	NCT07091630	A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP	argenx	Phase 3	Recruiting	Chronic Inflammatory Demyelinating Polyneuropathy, CIDP, Chronic Inflammatory Demyelinating Polyradiculoneuropathy	160	Argentina, Austria, Brazil, Bulgaria, China, Colombia, Czechia, Denmark...	clinicaltrials.gov
July 24, 2025	NCT07082426	Early System Experience With the Abbott Balloon-expandable TAVI System: First-In-Human Study	Abbott Medical Devices	Not applicable	Active not recruiting	Symptomatic Severe Aortic Stenosis	8	Georgia, Uzbekistan	clinicaltrials.gov
July 23, 2025	NCT07080242	Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors	SystImmune Inc.	Phase 1	Recruiting	Small Cell Lung Cancer Metastatic or Locally Advanced, Neuroendocrine Cancer, Metastatic Neuroendocrine Prostate...	120	Georgia, Ukraine, United States	clinicaltrials.gov
July 17, 2025	NCT07069712	A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal...	AstraZeneca	Phase 2	Recruiting	Gastroesophageal Adenocarcinoma	100	Canada, China, Georgia, Italy, Japan, Poland, Spain, Taiwan, Turkey (Türkiye)...	clinicaltrials.gov
July 16, 2025	NCT07067463	A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis	Zenas BioPharma (USA), LLC	Phase 3	Recruiting	Multiple Sclerosis (MS) Primary Progressive	705	Australia, Bulgaria, Croatia, Czechia, Estonia, Georgia, Germany, Italy...	clinicaltrials.gov
June 30, 2025	NCT07044336	Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)	AstraZeneca	Phase 3	Recruiting	Endometrial Cancer, Malignant Solid Tumour	800	Argentina, Australia, Austria, Belgium, Brazil, Canada, China, Czechia...	clinicaltrials.gov
June 26, 2025	NCT07039916	Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis	Immunovant Sciences GmbH	Phase 3	Recruiting	Generalized Myasthenia Gravis	231	Argentina, Czechia, Denmark, Georgia, Germany, Greece, Hungary, Italy, Mexico...	clinicaltrials.gov
June 26, 2025	NCT07037875	A Study Comparing the Effect and Safety of Linaprazan Glurate to Lansoprazole in Participants With Erosive Esophagitis (EE) Due to...	Cinclus Pharma Holding AB	Phase 3	Completed	GERD (Gastroesophageal Reflux Disease)	523	Bulgaria, Czechia, Georgia, Germany, Hungary, Poland, Romania, Serbia	clinicaltrials.gov
June 25, 2025	NCT07037771	A Phase 3 Study of Zodasiran in Adolescent and Adult Subjects With Homozygous Familial Hypercholesterolemia (YOSEMITE)	Arrowhead Pharmaceuticals	Phase 3	Active not recruiting	Homozygous Familial Hypercholesterolemia	70	Australia, Austria, Belgium, Brazil, Canada, Czechia, France, Georgia, Germany...	clinicaltrials.gov
June 24, 2025	NCT07033026	An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer...	NGM Biopharmaceuticals, Inc	Phase 2	Recruiting	Colorectal Cancer, CRC (Colorectal Cancer), Cancer Cachexia	136	Georgia, South Korea, Taiwan, United States	clinicaltrials.gov

Sponsors posting most

Sponsor	New trials	Latest
AstraZeneca	7	October 1, 2026
Immunovant Sciences GmbH	6	December 16, 2025
Sanofi	6	September 24, 2025
argenx	5	May 28, 2026
Boehringer Ingelheim	4	March 27, 2026
Arrowhead Pharmaceuticals	4	November 3, 2025
Regeneron Pharmaceuticals	3	July 13, 2026
Spyre Therapeutics, Inc.	3	June 17, 2026
Incyte Corporation	3	June 3, 2026
BioNTech SE	3	September 15, 2025
Dianthus Therapeutics	2	June 15, 2026
University Hospital Schleswig-Holstein	2	June 4, 2026
SystImmune Inc.	2	June 4, 2026
TG Therapeutics, Inc.	2	March 31, 2026
Shanghai Henlius Biotech	2	March 17, 2026
UCB Biopharma SRL	2	March 11, 2026
Janssen Research & Development, LLC	2	February 27, 2026
Zenas BioPharma (USA), LLC	2	December 23, 2025
Mirum Pharmaceuticals, Inc.	2	December 23, 2025
Insmed Incorporated	2	November 18, 2025

Conditions

Condition group	New trials	Latest
Colitis, Ulcerative	9	September 29, 2026
Arthritis, Rheumatoid	8	August 21, 2026
Carcinoma, Non-Small-Cell Lung	8	February 6, 2026
Pulmonary Disease, Chronic Obstructive	5	July 6, 2026
Myasthenia Gravis	5	June 15, 2026
Lung Neoplasms	5	June 4, 2026
Graves Disease	5	May 19, 2026
Neoplasms	5	April 20, 2026
Inflammatory Bowel Diseases	4	September 29, 2026
Neoplasm Metastasis	4	May 1, 2026
Lupus Erythematosus, Systemic	4	February 27, 2026
Heart Failure	4	February 12, 2026
Colitis	3	September 29, 2026
Mitral Valve Insufficiency	3	September 1, 2026
Autoimmune Diseases	3	August 21, 2026
Small Cell Lung Carcinoma	3	June 4, 2026
Pancreatic Neoplasms	3	May 1, 2026
Melanoma	3	March 17, 2026
Hepatitis D	3	December 23, 2025
Colorectal Neoplasms	3	December 16, 2025
Leukemia, Myeloid, Acute	3	October 8, 2025
Crohn Disease	3	September 22, 2025
Breast Neoplasms	3	September 15, 2025
Fallopian Tube Neoplasms	2	October 1, 2026
Venous Thromboembolism	2	July 13, 2026

By phase

Phase	New trials	Latest
Phase 3	58	November 3, 2026
Phase 2	30	September 29, 2026
Phase 1	24	May 28, 2026
Not applicable	20	November 4, 2026
Phase 1/2	6	October 5, 2026
Phase 2/3	5	March 16, 2026
Observational	5	February 2, 2026

Where the register publishes

U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.